The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial

Autoria(s): Oscier, D.G.; Rose-Zerilli, M.J.J.; Winkelmann, N.; de Castro, D.G.; Gomez, B.; Forster, J.; Parker, H.; Parker, A.; Gardiner, A.; Collins, A.; Else, M.; Cross, N.C.P.; Catovsky, D.; Strefford, J.C.
Data(s)

17/01/2013
Identificador

http://pure.qub.ac.uk/portal/en/publications/the-clinical-significance-of-notch1-and-sf3b1-mutations-in-the-uk-lrf-cll4-trial(7dbe93f3-4ccc-484c-8f14-f6521e61e8aa).html

http://dx.doi.org/10.1182/blood-2012-05-429282
Idioma(s)

eng
Direitos

info:eu-repo/semantics/restrictedAccess
Fonte

Oscier , D G , Rose-Zerilli , M J J , Winkelmann , N , de Castro , D G , Gomez , B , Forster , J , Parker , H , Parker , A , Gardiner , A , Collins , A , Else , M , Cross , N C P , Catovsky , D & Strefford , J C 2013 , ' The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial ' Blood , vol 121 , no. 3 , pp. 468-475 . DOI: 10.1182/blood-2012-05-429282
Tipo

article
Acesso ao item digital